Flputnam Investment Management Co. Sells 4,033 Shares of SPDR S&P Biotech ETF $XBI

Flputnam Investment Management Co. decreased its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 19.8% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 16,315 shares of the exchange traded fund’s stock after selling 4,033 shares during the quarter. Flputnam Investment Management Co.’s holdings in SPDR S&P Biotech ETF were worth $1,635,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently made changes to their positions in the business. Wellington Management Group LLP raised its position in shares of SPDR S&P Biotech ETF by 56.2% in the first quarter. Wellington Management Group LLP now owns 101,946 shares of the exchange traded fund’s stock valued at $8,268,000 after buying an additional 36,696 shares in the last quarter. CW Advisors LLC increased its stake in SPDR S&P Biotech ETF by 7.8% during the 1st quarter. CW Advisors LLC now owns 22,021 shares of the exchange traded fund’s stock worth $1,791,000 after acquiring an additional 1,585 shares during the period. SVB Wealth LLC acquired a new position in SPDR S&P Biotech ETF in the 1st quarter valued at $109,000. MetLife Investment Management LLC acquired a new position in SPDR S&P Biotech ETF in the 1st quarter valued at $156,000. Finally, Transamerica Financial Advisors LLC lifted its position in shares of SPDR S&P Biotech ETF by 4.9% during the 1st quarter. Transamerica Financial Advisors LLC now owns 5,732 shares of the exchange traded fund’s stock valued at $465,000 after acquiring an additional 267 shares during the period.

SPDR S&P Biotech ETF Stock Performance

XBI opened at $125.91 on Tuesday. SPDR S&P Biotech ETF has a 52-week low of $66.66 and a 52-week high of $126.50. The firm has a market cap of $7.64 billion, a P/E ratio of 11.47 and a beta of 0.93. The business’s fifty day moving average is $115.61 and its 200-day moving average is $99.12.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.